Nearly 200 dentists shared best practices, including pertinent issues and latest advancements in treatment of gum disease at a recent symposium in Riyadh.

GlaxoSmithKline (GSK) Consumer Healthcare’s parodontax oral care brand organised a dental lecture titled ‘Dentists Scientific Bridge’ at the Sheraton Hotel.

The event aimed to highlight latest advances in the treatment of gum diseases, specifically gingival and periodontal diseases.

“Certain dental conditions such as bleeding gums are often ignored as people presume this to be a harmless problem. What they do not realise is that these seemingly risk-free conditions could be a sign of gum disease and if left untreated could lead to more serious chronic inflammatory diseases or even tooth loss,” said Dr Khalid Al Hamdan, assistant professor and head, division of periodontics, dentistry college, King Saud University.

“One of the objectives of organising this lecture was to highlight and raise awareness for gum disease and the importance of treating gum problems, especially given today’s advancements in dental technology and medical sciences.”

“The symposium presented an ideal platform for dental experts to share their experience and highlight ways through which people can pay greater attention to oral health. We believe the event has provided the impetus to conduct similar initiatives that will benefit both the dental fraternity and the community at large,” added Dr Al Hamdan. – TradeArabia News Service